Lymphoma stage at diagnosis may predict when and where new cancer forms
A new study shows the stage at which lymphoma is originally diagnosed impacts the types of second cancers that may form after treatment.
Read moreA new study shows the stage at which lymphoma is originally diagnosed impacts the types of second cancers that may form after treatment.
Read moreBreast cancer is one of the most prevalent cancers, and some forms rank among the most difficult to treat. Its various types and involvement of many different cells makes targeting such tumors difficult. Now, researchers have used a state-of-the-art technology to profile each cell during normal breast development in order to understand what goes wrong in cancer.
Read moreResearchers have identified cells containing a protein called Meflin that has a role in restraining the progression of pancreatic cancer. They have also shown that cancer progression can be controlled by artificially increasing the amount of this protein in the cells.
Read moreResearchers report tumor's molecular profiles that might better predict meningioma recurrence.
Read moreResearchers have successfully grown human, testosterone-producing cells in the lab, paving the way to someday treat low testosterone with personalized replacement cells.
Read moreResearchers have identified a pair of proteins believed to be critical for spreading, or metastasizing, breast cancer to bone.
Read moreScientists have carried out one of the most comprehensive studies into how immune cells sense and respond to their environment to fight infection and destroy tumors. The research team said the results provide important insights into how immune responses might be manipulated for the treatment of autoimmune diseases and cancer.
Read moreThe discovery suggests new avenues for devising treatments and is a vital step toward finding a cure.
Read more
The 2019 Nobel Prize in Physiology or Medicine is being awarded jointly to William G. Kaelin Jr., Sir Peter J. Ratcliffe and Gregg L. Semenza for identifying molecular machinery that regulates the activity of genes in response to varying levels of oxygen.
A new type of drug that blocks one of cancer's key evolutionary escape routes from chemotherapy could be used to treat aggressive breast cancers, a new study has shown.
Read more